Syneos Health, Inc. Class A Common Stock
SYNH
SYNH was delisted on the 27th of September, 2023.
240 hedge funds and large institutions have $5.67B invested in Syneos Health, Inc. Class A Common Stock in 2018 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 120 increasing their positions, 44 reducing their positions, and 16 closing their positions.
175% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 16
173% more repeat investments, than reductions
Existing positions increased: 120 | Existing positions reduced: 44
141% more call options, than puts
Call options by funds: $3.26M | Put options by funds: $1.35M
13% more funds holding
Funds holding: 213 → 240 (+27)
9% more capital invested
Capital invested by funds: $5.2B → $5.67B (+$469M)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$60.8M |
| 2 |
BlackRock
New York
|
+$36.8M |
| 3 |
ECM
Element Capital Management
New York
|
+$31.8M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$30.6M |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$22.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
THLTP
Thomas H. Lee (THL) Partners
Boston,
Massachusetts
|
-$292M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$36.2M |
| 3 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$35M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$27.1M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$20.9M |
SYNH Hedge Fund Activity: Q3 2018 in Review
240 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Syneos Health, Inc. Class A Common Stock (SYNH) for Q3 2018, worth a combined $5.67B — up 9% from $5.2B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new SYNH positions and 16 closed out — a net gain of 28 holders — while 120 added to existing stakes and 44 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $60.8M. The largest seller was Thomas H. Lee (THL) Partners, cutting an estimated $292M.
- 240 institutional investors held Syneos Health, Inc. Class A Common Stock (SYNH) as of Q3 2018, up from 213 in Q2 2018.
- Funds reported $5.67B of Syneos Health, Inc. Class A Common Stock stock for Q3 2018, up 9% quarter-over-quarter.
- 44 funds opened new Syneos Health, Inc. Class A Common Stock positions in Q3 2018 and 16 closed out, a net change of +28 holders.
- The largest Syneos Health, Inc. Class A Common Stock buyer in Q3 2018 was JP Morgan Chase, an estimated $60.8M added.
- The largest Syneos Health, Inc. Class A Common Stock seller in Q3 2018 was Thomas H. Lee (THL) Partners, an estimated $292M sold.
Based on aggregated 13F filings for Q3 2018.